Clinical Trial Update: Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating omega-3 fatty acid supplementation to prevent preterm birth in high-risk pregnancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Omega-3 fatty acid supplementation (Omega-3 fatty acids)

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Preterm Birth | Phase 3 | Status: COMPLETED